Protein Hydrolysate Market Size

Protein Hydrolysate Market Size

Protein Hydrolysate Market size was above USD 500 million in 2016 and expects consumption of over 160 kilo tons by 2024
 

Positive application outlook in from infant, sports and clinical should drive protein hydrolysate demand. Increasing income levels along with shift in consumer preferences towards nutritional products will drive the growth. Easy digestibility of these products as compared to intact proteins gives them as edge for usage in infant formulas. Strong growth rate can be expected from prepared baby food industry which is bolstered by increasing demand from working mothers with busy working schedule and lack of time to prepare healthy meals. Increased consumer awareness about nutritional content in foods will drive global protein hydrolysates market size.
 

Global infant formula market was over 22 billion in 2016. The market should continue to witness steady gains with rapid urbanization and burgeoning middle-class population base in China, India, Thailand and Malaysia which is likely to fuel product demand. Asia Pacific is anticipated to remain the largest market for infant formula, accounting to be over 45% of the global revenue share in 2016.
 

Europe and China have imposed strict regulations regarding usage of nutritional products in food and feed applications. According to the Chinese regulation protein hydrolysate supplement should contain minimum 50% of premium protein. The name of hydrolysed based products should be specified based on plant source like pea or corn based nutritional products. According to FDA Sec. 573.200 the moisture content in these products (when used as an additive) should not be less than 45 percent by weight and not over 50 percent by weight.
 

Neurodegenerative disorders are one of the leading causes of disability and deaths in both developing and developed countries. Medical science makes use of neurotrophic drugs to treat the same. Cerebroprotein hydrolysate is latest and promising drug used in treatment of various neurological disorders. It is a brain protein extracted from animal source (animal brains). It is majorly used for treatment of brain injuries and neurogenerative conditions ranging from mild to severe by directly act on the brain to help in repairing and protect neurons in a faster way than any other neurotrophic agent. It acts as an effective tool for improving levels of activities of daily living in patients with various neural sicknesses and reducing their dependence on caregivers. 

The products are made by hydrolysing the intact proteins. More than half of these products are made from milk which are whey and casein. Fluctuation in raw material costs may affect protein hydrolysates market price trend.